SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-23-034074
Filing Date
2023-07-11
Accepted
2023-07-11 16:30:36
Documents
2
Period of Report
2023-07-06

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1388
2 EXHIBIT 24.1 brhc20055767_ex24-1.htm EX-24.1 11997
  Complete submission text file 0001140361-23-034074.txt   15207
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Issuer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRUST CO OF THE SWEST 200 PARK AVE SUITE 220 NEW YORK NY 01066
Business Address
BINDER BRANT (Reporting) CIK: 0001133594 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 231082424
SIC: 7374 Services-Computer Processing & Data Preparation